|국가/구분||United States(US) Patent 등록|
|국제특허분류(IPC7판)||C07C-045/00 C07C-049/115 C07C-049/00 C07D-311/78 C07D-311/00 C07D-315/00 A61K-031/00|
|미국특허분류(USC)||568/311; 568/327; 549/381; 549/416; 514/681; 514/732|
|발명자 / 주소|
|출원인 / 주소|
|대리인 / 주소||
|인용정보||피인용 횟수 : 4 인용 특허 : 8|
The present invention provides novel benzotropolone derivatives represented by the general formula: including neotheaflavate B and EGCGCa. The benzotropolone derivatives of the present invention are effective antioxidant and anti-inflammatory agents. The present invention also provides novel method of synthesizing benzotropolone compounds in high yields and method of treating inflammatory conditions using benzotropolone containing compounds.
What is claimed is: 1. Neotheaflavate B or a salt or an ester thereof. 2. EGCGCa (Epigallocatechinocatechol gallate) or a salt or an ester thereof. 3. A composition comprising the neotheaflavate B or a salt or an ester thereof of claim 1. 4. A composition comprising the EGCGCa or a salt or an ester thereof of claim 2. 5. The composition of claim 4, further comprising a pharmaceutically acceptable carrier or diluent, wherein said composition is effective as an anti-inflammatory agent or antioxidant. 6. The composition of claim 4, wherein the co...